BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
10.53
+1.49 (16.48%)
Aug 3, 2026, 11:05 AM EDT - Market open
BioAge Labs Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, BioAge Labs stock has a consensus rating of "Buy" and an average price target of $39.88. The average 1-year stock price forecast is 278.73% higher than the current stock price, while the lowest is $21 (+99.43%) and the highest is $73 (+593.26%).
Price Target: $39.88 (+278.73%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BioAge Labs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 5 | 5 | 5 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $40 | Buy | Maintains | $40 | +279.87% | Aug 3, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $36 → $25 | Buy | Maintains | $36 → $25 | +137.42% | Aug 3, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 1, 2026 |
| Jefferies | Jefferies | Buy Maintains $62 → $21 | Buy | Maintains | $62 → $21 | +99.43% | Jul 31, 2026 |
| Citi | Citi | Buy Maintains $52 | Buy | Maintains | $52 | +393.83% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
54.29M
from 9.00M
Increased by 503.61%
Revenue Next Year
35.95M
from 54.29M
Decreased by -33.79%
EPS This Year
-2.48
from -2.24
EPS Next Year
-2.04
from -2.48
EPS and Forward PE are based on non-GAAP adjusted numbers.